Results
1 -
10 of
27
(Click
here to explore results)
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 9 Iron Metabolism in Parkinson’s Disease. Guofen Gao, Lin-Hao You, Yan-Zhong Chang
, 2017
, Pages 255-276
- Animal Models for Neurodegenerative Disease, Chapter 6 Animal Models of Parkinson's Disease. Hardy J. Rideout, Leonidas Stefanis
, 2011
, Pages 86-112
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents. Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
- Natural Product Chemistry for Drug Discovery, Chapter 12 From Natural Product to Clinical Trials: NPI-0052 (Salinosporamide A), a Marine Actinomycete-Derived Anticancer Agent. Kin S. Lam, G. Kenneth Lloyd, Saskia T. C. Neuteboom, Michael A. Palladino, Kobi M. Sethna, Matthew A. Spear, Barbara C. Potts
, 2009
, Pages 355-373
- Amino Acids, Peptides and Proteins: Volume 31, Amino acids. J. S. Davies, Graham C. Barrett
, 2000
, Volume 31
, Pages 1-119
- Nuclear Magnetic Resonance: Volume 46, NMR in living systems. M. J. W. Prior
, 2021
, Volume 46
, Pages 272-322
- Small-molecule Transcription Factor Inhibitors in Oncology, Chapter 3 Natural Products as Promising Leads Against Oncogenic Transcription Factors and Associated Signalling Pathways. Taufiq Rahman, Xavier Chee Wezen
, 2019
, Pages 55-80
- Economic Synthesis of Heterocycles: Zinc, Iron, Copper, Cobalt, Manganese and Nickel Catalysts, CHAPTER 4 Copper-Catalyzed Heterocycle Synthesis
, 2014
, Pages 159-348
- Animal Models for Neurodegenerative Disease, Chapter 7 Animal Models and the Pathogenesis of Parkinson's Disease. José G. Castaño, Teresa Iglesias, Justo G. de Yébenes
, 2011
, Pages 113-161
- Sustainable Organic Synthesis: Tools and Strategies, CHAPTER 6 Colored Compounds for Eco-sustainable Visible-light Promoted Syntheses. Maurizio Fagnoni
, 2022
, Pages 150-180